Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

A pH-Mediated Topological Switch within the N-Terminal Domain of Human Caveolin-3.

Kim JH, Schlebach JP, Lu Z, Peng D, Reasoner KC, Sanders CR.

Biophys J. 2016 Jun 7;110(11):2475-2485. doi: 10.1016/j.bpj.2016.05.004.

2.

Structural and dynamic properties of juxta-membrane segments of caveolin-1 and caveolin-2 at the membrane interface.

Le Lan C, Gallay J, Vincent M, Neumann JM, de Foresta B, Jamin N.

Eur Biophys J. 2010 Jan;39(2):307-25. doi: 10.1007/s00249-009-0548-4. Epub 2009 Oct 22.

PMID:
19847421
3.

Modest effects of lipid modifications on the structure of caveolin-3.

Kim JH, Peng D, Schlebach JP, Hadziselimovic A, Sanders CR.

Biochemistry. 2014 Jul 15;53(27):4320-2. doi: 10.1021/bi5005238. Epub 2014 Jun 26.

4.

The transmembrane domain of caveolin-1 exhibits a helix-break-helix structure.

Lee J, Glover KJ.

Biochim Biophys Acta. 2012 May;1818(5):1158-64. doi: 10.1016/j.bbamem.2011.12.033. Epub 2012 Jan 4.

5.
6.

Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.

Traverso M, Gazzerro E, Assereto S, Sotgia F, Biancheri R, Stringara S, Giberti L, Pedemonte M, Wang X, Scapolan S, Pasquini E, Donati MA, Zara F, Lisanti MP, Bruno C, Minetti C.

Lab Invest. 2008 Mar;88(3):275-83. doi: 10.1038/labinvest.3700713. Epub 2008 Feb 4.

7.

Caveolae regulation of mechanosensitive channel function in myotubes.

Huang H, Bae C, Sachs F, Suchyna TM.

PLoS One. 2013 Aug 30;8(8):e72894. doi: 10.1371/journal.pone.0072894. eCollection 2013.

8.

Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.

Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F.

Nat Genet. 1998 Apr;18(4):365-8.

PMID:
9537420
9.

The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.

Hedley PL, Kanters JK, Dembic M, Jespersen T, Skibsbye L, Aidt FH, Eschen O, Graff C, Behr ER, Schlamowitz S, Corfield V, McKenna WJ, Christiansen M.

Circ Cardiovasc Genet. 2013 Oct;6(5):452-61. doi: 10.1161/CIRCGENETICS.113.000137. Epub 2013 Sep 10.

PMID:
24021552
10.

Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning.

Nixon SJ, Wegner J, Ferguson C, Méry PF, Hancock JF, Currie PD, Key B, Westerfield M, Parton RG.

Hum Mol Genet. 2005 Jul 1;14(13):1727-43. Epub 2005 May 11.

PMID:
15888488
11.

Secondary Structure Analysis of a Functional Construct of Caveolin-1 Reveals a Long C-Terminal Helix.

Plucinsky SM, Glover KJ.

Biophys J. 2015 Oct 20;109(8):1686-8. doi: 10.1016/j.bpj.2015.08.030.

12.

Direct molecular interaction of caveolin-3 with KCa1.1 channel in living HEK293 cell expression system.

Suzuki Y, Yamamura H, Ohya S, Imaizumi Y.

Biochem Biophys Res Commun. 2013 Jan 18;430(3):1169-74. doi: 10.1016/j.bbrc.2012.12.015. Epub 2012 Dec 10.

PMID:
23237801
13.

Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter.

Li H, Li F, Sun H, Qian ZM.

Biochem J. 2003 Jun 15;372(Pt 3):757-66.

14.

Dystrophy-associated caveolin-3 mutations reveal that caveolae couple IL6/STAT3 signaling with mechanosensing in human muscle cells.

Dewulf M, Köster DV, Sinha B, Viaris de Lesegno C, Chambon V, Bigot A, Bensalah M, Negroni E, Tardif N, Podkalicka J, Johannes L, Nassoy P, Butler-Browne G, Lamaze C, Blouin CM.

Nat Commun. 2019 Apr 29;10(1):1974. doi: 10.1038/s41467-019-09405-5.

15.

Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.

Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H, Ma J.

J Biol Chem. 2009 Jun 5;284(23):15894-902. doi: 10.1074/jbc.M109.009589. Epub 2009 Apr 20.

16.

Structural study of caveolin-1 intramembrane domain by circular dichroism and nuclear magnetic resonance.

Yang G, Dong Z, Xu H, Wang C, Li H, Li Z, Li F.

Biopolymers. 2015 Jan;104(1):11-20. doi: 10.1002/bip.22597.

PMID:
25471446
17.

The coiled-coil domain of MURC/cavin-4 is involved in membrane trafficking of caveolin-3 in cardiomyocytes.

Naito D, Ogata T, Hamaoka T, Nakanishi N, Miyagawa K, Maruyama N, Kasahara T, Taniguchi T, Nishi M, Matoba S, Ueyama T.

Am J Physiol Heart Circ Physiol. 2015 Dec 15;309(12):H2127-36. doi: 10.1152/ajpheart.00446.2015. Epub 2015 Oct 23.

18.
19.

The Caveolin-3 P104L mutation of LGMD-1C leads to disordered glucose metabolism in muscle cells.

Deng YF, Huang YY, Lu WS, Huang YH, Xian J, Wei HQ, Huang Q.

Biochem Biophys Res Commun. 2017 Apr 29;486(2):218-223. doi: 10.1016/j.bbrc.2017.02.072. Epub 2017 Feb 21.

PMID:
28232187
20.

Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.

Ye B, Balijepalli RC, Foell JD, Kroboth S, Ye Q, Luo YH, Shi NQ.

Biochemistry. 2008 Nov 25;47(47):12312-8.

Supplemental Content

Support Center